Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy.
See All Pages
Find People
Find Everything
Edit My Profile
My Person List (
0
)
Opportunity Search
Due to system maintenance, login and edit functionaility is currently unavailable
Return to Top
Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy.
Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy. Mol Ther. 2000 Dec; 2(6):545-51.
View in:
PubMed
subject areas
Animals
Base Sequence
Carbon Tetrachloride
DNA Primers
Enzyme-Linked Immunosorbent Assay
Liver Cirrhosis, Experimental
Liver Regeneration
Rats
Rats, Wistar
Urokinase-Type Plasminogen Activator